Cormorant Global Healthcare Master Fund, LP
SEC CIK 1618442 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | Former 10% Owner | 2.00M | — | $46.87M | 1 | 2025-09-29 | 2025-09-29 |
| OKUR | OnKure Therapeutics, Inc. | 10% | 1.81M | — | $48.4K | 1 | 2025-05-12 | 2025-05-12 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | 10% | 864.7K | $3.23M | — | 1 | 2024-10-15 | 2024-10-15 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 10% | 2.35M | $7.00M | — | 1 | 2024-09-20 | 2024-09-20 |
| EYPT | EyePoint, Inc. | 10% | 7.29M | $52.36M | — | 2 | 2023-12-04 | 2024-04-18 |
| IMRX | Immuneering Corp | 10% | 3.86M | — | $2.75M | 1 | 2024-03-14 | 2024-03-14 |
| BMEA | Biomea Fusion, Inc. | 10% | 3.57M | $12.00M | — | 1 | 2023-03-30 | 2023-03-30 |
| JBIO | Jade Biosciences, Inc. | Former 10% Owner | 1.53M | $7.00M | — | 2 | 2021-07-02 | 2021-07-02 |
Most active insiders at MLTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BVF PARTNERS L P/IL | Dir, 10% | — | $62.96M |
| 2 | Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | — | $46.87M |
| 3 | Santos da Silva Jorge | CEO, Dir | — | $8.73M |
| 4 | Reich Kristian | CSO | — | $8.14M |
| 5 | Bodenstedt Matthias | CFO | $98.8K | $3.20M |
Transactions 10
Purchase Sale Sale after option exercise All abbreviations